Correlation Between Lantern Pharma and Immunome

Can any of the company-specific risk be diversified away by investing in both Lantern Pharma and Immunome at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lantern Pharma and Immunome into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lantern Pharma and Immunome, you can compare the effects of market volatilities on Lantern Pharma and Immunome and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lantern Pharma with a short position of Immunome. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lantern Pharma and Immunome.

Diversification Opportunities for Lantern Pharma and Immunome

0.31

Correlation Coefficient

Lantern Pharma  Immunome

Weak diversification

The 3 months correlation between Lantern and Immunome is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Lantern Pharma and Immunome in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunome and Lantern Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lantern Pharma are associated (or correlated) with Immunome. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunome has no effect on the direction of Lantern Pharma i.e., Lantern Pharma and Immunome go up and down completely randomly.

Pair Corralation between Lantern Pharma and Immunome

Given the investment horizon of 90 days Lantern Pharma is expected to generate 1.38 times more return on investment than Immunome. However, Lantern Pharma is 1.38 times more volatile than Immunome. It trades about 0.05 of its potential returns per unit of risk. Immunome is currently generating about -0.11 per unit of risk. If you would invest  327.00  in Lantern Pharma on December 30, 2024 and sell it today you would earn a total of  28.00  from holding Lantern Pharma or generate 8.56% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Lantern Pharma  vs.  Immunome

Lantern Pharma

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Lantern Pharma are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Lantern Pharma displayed solid returns over the last few months and may actually be approaching a breakup point.

Immunome

Risk-Adjusted Performance

Very Weak

Over the last 90 days Immunome has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Lantern Pharma and Immunome

The main advantage of trading using opposite Lantern Pharma and Immunome positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lantern Pharma position performs unexpectedly, Immunome can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunome will offset losses from the drop in Immunome's long position.

The idea behind Lantern Pharma and Immunome pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.